Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes

BACKGROUND/AIM: To assess visual acuity (VA) outcomes and antivascular endothelial growth factor (anti-VEGF) treatment intensity in diabetic macular oedema (DMO). METHODS: Retrospective analysis was performed in treatment-naïve patients with DMO from 2013 to 2018 using a database of aggregated de-id...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciulla, Thomas A, Pollack, John S, Williams, David F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848066/
https://www.ncbi.nlm.nih.gov/pubmed/32265201
http://dx.doi.org/10.1136/bjophthalmol-2020-315933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848066/
https://www.ncbi.nlm.nih.gov/pubmed/32265201
http://dx.doi.org/10.1136/bjophthalmol-2020-315933

Ejemplares similares